Understanding heart disease with T1 mapping MRI
Part of Genetic & congenital, Heart & circulation clinical trials.
This study uses a special type of MRI (T1 mapping) to better understand different heart conditions. It may help doctors improve diagnosis and treatment by looking at detailed images of your heart muscle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a specific heart condition, such as cardiomyopathy, heart attack, valve disease, or other listed types.
- Your diagnosis is confirmed by tests like echocardiogram, MRI, lab work, or biopsy.
- You do not have multiple heart conditions at the same time (for example, both cardiomyopathy and valve disease).
- You are able to have an MRI safely (no metal implants or pacemakers), and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses heart MRI scans to find markers that predict outcomes in people with ischemic heart disease, including those who have had a heart attack. It may help doctors better understand your condition and guide future care.
This study checks whether an MRI heart scan measure called “T1 mapping” can improve how doctors estimate heart disease risk in everyday people. You may join if you’re an adult and can have a contrast-enhanced heart MRI safely.
This study uses advanced magnetic resonance imaging (MRI) scans to better understand and diagnose heart disease. If you have suspected or confirmed heart problems, this trial may help doctors get clearer pictures of your heart muscle and tissue to figure out what's causing your symptoms.
This study uses a special heart MRI to look closely at inflammation in the heart muscle. It helps doctors better understand and treat myocarditis and inflammatory cardiomyopathy.
This study uses heart MRI scans to predict who might develop dangerous heart rhythms. It's for people with certain types of non-ischemic heart disease who have already had an MRI with contrast.
This trial uses a heart MRI to measure details in people with dilated cardiomyopathy and reduced pumping strength. It aims to use these MRI findings to better predict your future heart risk and guide care.
Hear when a new Hypertrophic Cardiomyopathy (HCM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.